Antiviral Research 48 (2000) 209 – 210
Author index
Volume 48 (2000)
Addison, W.R., W.W.S. Wong, K.P. Fischer, D.L.J. Tyrrell, A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus 48, 27
Agrawal, S., see Lewis, E.J. 48, 187
Alper, R., see Gotsman, I. 48, 17
Baron, S., I. Singh, A. Chopra, D. Coppenhaver, J. Pan, Innate antiviral defenses in body fluids and tissues 48, 71
Baron, S., see Pan, J. 48, 39
Beinart, R., see Gotsman, I. 48, 17
Bishop, J., see Lewis, E.J. 48, 187 Bonsignore, L., see De Logu, A. 48, 177
Budgeon, L.R., see Christensen, N.D. 48, 131
Butera, S.T., Therapeutic targeting of human immunodefi-ciency virus type-1 latency: current clinical realities and future scientific possibilities 48, 143
Chadwick, J., see Lewis, E.J. 48, 187
Chopra, A.K., see Pan, J. 48, 39
Chopra, A., see Baron, S. 48, 71
Christensen, N.D., M.D. Pickel, L.R. Budgeon, J.W. Kreider, In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillo-mas 48, 131
Clark, J.M., see Genovesi, E.V. 48, 197 Colonno, R.J., see Genovesi, E.V. 48, 197
Coppenhaver, D.H., see Pan, J. 48, 39
Coppenhaver, D., see Baron, S. 48, 71
Cristensen, N.D., see Lewis, E.J. 48, 187 Cuconati, A., see Verlinden, Y. 48, 61
Cuthill, S., see Lewis, E.J. 48, 187
De Clercq, E., see Moya, J. 48, 125
De Clercq, E., see Ying, C. 48, 117
De Logu, A., G. Loy, M.L. Pellerano, L. Bonsignore, M.L. Schivo, Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil 48, 177
Dunford, P., see Lewis, E.J. 48, 187
Engelhardt, D., see Gotsman, I. 48, 17 Field, A.K., see Lewis, E.J. 48, 187 Fischer, K.P., see Addison, W.R. 48, 27
Francis, J., see Lewis, E.J. 48, 187
Genovesi, E.V., L. Lamb, I. Medina, D. Taylor, M. Seifer, S. Innaimo, R.J. Colonno, J.M. Clark, Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection 48, 197 Gibson, V., see Lewis, E.J. 48, 187
Gilray, J.A., see Nettleton, P.F. 48, 205
Goloubeva, O.G., see Leneva, I.A. 48, 101
Gotsman, I., R. Beinart, R. Alper, E. Rabbani, D. Engelhardt, Y. Ilan, Induction of oral tolerance towards hepatitis B envelope antigens in a murine model 48, 17
Govorkova, E.A., see Leneva, I.A. 48, 101
Greenham, A.K., see Lewis, E.J. 48, 187
Hahn, M., see Zimmermann, A. 48, 49 Ilan, Y., see Gotsman, I. 48, 17
Innaimo, S., see Genovesi, E.V. 48, 197
Jashe´s, M., see Moya, J. 48, 125
Kelly, F., see Lewis, E.J. 48, 187
Kilkushie, R., see Lewis, E.J. 48, 187
Kimball, P.M., see Shiffman, M.L. 48, 91 Kreider, J.W., see Christensen, N.D. 48, 131
Kreider, J.W., see Lewis, E.J. 48, 187
Kurosky, A., see Pan, J. 48, 39
Lamb, L., see Genovesi, E.V. 48, 197
Author index
210
Leneva, I.A., N. Roberts, E.A. Govorkova, O.G. Goloubeva, R.G. Webster, The neuraminidase inhibitor GS4104 (os-eltamivir phosphate) is efficacious against A/Hong Kong/ 156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses 48, 101
Lenhardt, M., see Zimmermann, A. 48, 49
Lewis, E.J., S. Agrawal, J. Bishop, J. Chadwick, N.D. Cristensen, S. Cuthill, P. Dunford, A.K. Field, J. Francis, V. Gibson, A.K. Greenham, F. Kelly, R. Kilkushie, J.W. Kreider, J.S. Mills, M. Mulqueen, N.A. Roberts, P. Roberts, D.E. Szymkowski, Non-specific antiviral activity of antisense molecules targeted to the E1 region of human papillomavirus 48, 187
Loy, G., see De Logu, A. 48, 177
Medina, I., see Genovesi, E.V. 48, 197
Mercer, A.A., see Nettleton, P.F. 48, 205
Mertens, T., see Zimmermann, A. 48, 49
Mills, J.S., see Lewis, E.J. 48, 187
Moya, J., H. Pizarro, M. Jashe´s, E. De Clercq, A.M. Sandino, In vivo effect of EICAR (5-ethynyl-1-b-D -ribofuranosylimi-dazole-carboxamide) on experimental infected rainbow trout (Oncorhynchus mykiss) and coho salmon (Oncorhynchus kisutch) fry with infectious pancreatic necrosis virus 48, 125
Mulqueen, M., see Lewis, E.J. 48, 187
Nettleton, P.F., J.A. Gilray, H.W. Reid, A.A. Mercer, Para-poxviruses are strongly inhibited in vitro by cidofovir 48,
205
Neyts, J., see Ying, C. 48, 117
Pan, J., A. Kurosky, B. Xu, A.K. Chopra, D.H. Coppenhaver, I.P. Singh, S. Baron, Broad antiviral activity in tissues of crustaceans 48, 39
Pan, J., see Baron, S. 48, 71
Pellerano, M.L., see De Logu, A. 48, 177
Pickel, M.D., see Christensen, N.D. 48, 131
Pizarro, H., see Moya, J. 48, 125 Rabbani, E., see Gotsman, I. 48, 17 Reid, H.W., see Nettleton, P.F. 48, 205 Roberts, N.A., see Lewis, E.J. 48, 187
Roberts, N., see Leneva, I.A. 48, 101
Roberts, P., see Lewis, E.J. 48, 187
Rombaut, B., see Verlinden, Y. 48, 61
Sandino, A.M., see Moya, J. 48, 125 Schivo, M.L., see De Logu, A. 48, 177 Seifer, M., see Genovesi, E.V. 48, 197
Shiffman, M.L., S.B. Verbeke, P.M. Kimball, Alpha interferon combined with ribavirin potentiates proliferative suppres-sion but not cytokine production in mitogenically stimulated human lymphocytes 48, 91
Sidwell, R.W., D.F. Smee, In vitro and in vivo assay systems for study of influenza virus inhibitors 48, 1
Singh, I.P., see Pan, J. 48, 39
Singh, I., see Baron, S. 48, 71
Smee, D.F., see Sidwell, R.W. 48, 1
Szymkowski, D.E., see Lewis, E.J. 48, 187
Taylor, D., see Genovesi, E.V. 48, 197
Tyrrell, D.L.J., see Addison, W.R. 48, 27
Verbeke, S.B., see Shiffman, M.L. 48, 91
Verlinden, Y., A. Cuconati, E. Wimmer, B. Rombaut, The antiviral compound 5-(3,4-dichlorophenyl) methylhydantoin inhibits the post-synthetic cleavages and the assembly of poliovirus in a cell-free system 48, 61
Webster, R.G., see Leneva, I.A. 48, 101
Wilts, H., see Zimmermann, A. 48, 49
Wimmer, E., see Verlinden, Y. 48, 61
Wong, W.W.S., see Addison, W.R. 48, 27
Xu, B., see Pan, J. 48, 39
Ying, C., E. De Clercq, J. Neyts, Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus 48,
117
Zimmermann, A., H. Wilts, M. Lenhardt, M. Hahn, T. Mertens, Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase 48, 49
